Posters

The efficacy of selective laser trabeculoplasty after trabeculectomy in open-angle glaucoma

Poster Details

First Author: C.Altan TURKEY

Co Author(s):    B. Duman   B. Basarir   I. Pasaoglu   B. Satana   T. Yasar   M. Taskapili     

Abstract Details

Purpose:

The aim of this study was to evaluate the efficacy and the safety of selective laser trabeculoplasty (SLT) in patients with open-angle glaucoma (OAG) in whom target intraocular pressure (IOP) was not attained following trabeculectomy and anti-glaucomatous therapy.

Setting:

Health Science University Beyoglu Eye Training and Research Hospital

Methods:

Patients who were diagnosed with advanced glaucoma and could not obtain the target IOP following one or more trabeculectomies and despite the application of one or several anti‑glaucoma medications were included in this study. Fourteen eyes of 14 patients were included into the study. The mean interval between trabeculectomy and SLT was 80,5 months. The patients were treated with 360° SLT. The IOP and the number of medications before and 1 week, 1 month, 3 months, 6 months, 9 months and 12 months after SLT, complications and additional surgeries were documented.

Results:

Prior to SLT, the patients had an average IOP of 21.0±3.2 mmHg under the mean number of 2.8±0.6 anti-glaucoma drugs. Following SLT, the average IOP was 21.0±4.9, 17.7±7.1, 17.8±7.7, 17.1±6.7, 14.8±7.2, 17.2±6.4 mmHg and the number of drug was 3.0, 3.0, 2.1±1.0, 2.4±0.7, 2.3±0.8, 2.5±0.7 in 1st week, 1st month, 3rd month, 6th month, 9th month and 12th month, respectively (p>0.05). Additional surgery was not indicated for eight patients. No complication was seen.

Conclusions:

This study demonstrated that SLT could reduce the IOP in post-trabeculectomy patients with OAG, even though this reduction is statistically insignificant, and no additional surgery was needed in more than half of the patients. Further studies with more patients are necessary to evaluate the efficacy of SLT after trabeculectomy.

Financial Disclosure:

None